See All Slides - tctmd.com

Slides

Presentation TCT 2017

My Worst Complication and What I Learned

Presenter: Satoru Sumitsuji, Simon J. Walsh

November 01, 2017

Presentation TCT 2017

FOURIER Trial: Topline Findings and Practice Implications

Presenter: Robert A. Harrington, Evan A. Stein, Wolfgang Koenig

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 7: TRAIPTA

Presenter: Francesco Maisano, Jason H. Rogers, Toby Rogers

November 01, 2017

Presentation TCT 2017

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No!

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation TCT 2017

Techniques for Treating Chronic Carotid Occlusion

Presenter: Brian G. DeRubertis, D. Christopher Metzger, Adnan Siddiqui

November 01, 2017

Presentation TCT 2017

How to Retrieve Embolized Hardware in the Cath Lab

Presenter: Vinay K. Bahl, Amal Kumar Banerjee, Upendra Kaul, Manotosh Panja

November 01, 2017

Presentation TCT 2017

Implications of Absolute Vessel Size and Scaffold-Vessel Size Mismatch

Presenter: Manel Sabate, Ashok Seth, Patrick W. Serruys

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status

Presenter: Deepak L. Bhatt, C. Michael Gibson, Renato D. Lopes

November 01, 2017

Presentation TCT 2017

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Presenter: Lee N. Benson, Megan Coylewright, Guillaume Turc

November 01, 2017

Advertisement

Slides

My Worst Complication and What I Learned

FOURIER Trial: Topline Findings and Practice Implications

Transcatheter TR Solution 7: TRAIPTA

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No!

Techniques for Treating Chronic Carotid Occlusion

How to Retrieve Embolized Hardware in the Cath Lab

Implications of Absolute Vessel Size and Scaffold-Vessel Size Mismatch

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content